Continuous Monitoring of Bladder Dysfunction in People With Multiple Sclerosis: Wearables for the Bladder
- PMID: 40693719
- DOI: 10.1002/acn3.70112
Continuous Monitoring of Bladder Dysfunction in People With Multiple Sclerosis: Wearables for the Bladder
Abstract
Background: Bladder dysfunction affects over 85% of people with multiple sclerosis (PwMS), yet current assessment methods are limited to periodic in-clinic evaluations or subjective patient reports, failing to capture real-world symptom fluctuations.
Objectives: To evaluate the feasibility and validity of using a novel remote bladder ultrasound device for home monitoring of bladder dysfunction in PwMS, comparing remote measurements with standard clinical assessments.
Methods: Twenty-two women with MS participated in this 3-month pilot study. Participants were asked to use the wearable ultrasound device at home for at least 3-5 days a month. Remote device measurements were compared with standard clinical data for post-void residual (rPVR vs. cPVR) and urinary frequency (rFrequency vs. 3-day bladder diary frequency). Agreement between measures was assessed using Bland-Altman analyses and correlation coefficients.
Results: Participants were middle-aged (mean 51.5 years; SD 9.3) with mild-moderate disability (median EDSS 4.0) and mostly relapsing MS (72.7%). Study retention was high (86.4%; 19/22), with mean device utilization of 14.1 days. Good agreement was seen between rPVR and cPVR (mean difference = 32.1 mL, SD = 38.6; 95% limits of agreement: -43.6, 107.9). The rFrequency measure also demonstrated a strong correlation with patient-reported frequency (ICC = 0.81, Pearson's r = 0.793, p = 0.002). Visualization of remote monitoring data revealed substantial day-to-day variability in bladder symptoms not captured by traditional assessments.
Conclusion: This pilot study demonstrates the feasibility and preliminary validity of using wearable ultrasound technology for remote monitoring of bladder dysfunction in PwMS. The ability to capture real-world symptom variations could transform assessment and management approaches, enabling more personalized and responsive care strategies.
Keywords: bladder dysfunction; digital health technology; multiple sclerosis; remote monitoring; wearables.
© 2025 The Author(s). Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Similar articles
-
Technology-enabled CONTACT tracing in care homes in the COVID-19 pandemic: the CONTACT non-randomised mixed-methods feasibility study.Health Technol Assess. 2025 May;29(24):1-24. doi: 10.3310/UHDN6497. Health Technol Assess. 2025. PMID: 40350743 Free PMC article.
-
Home telemonitoring and remote feedback between clinic visits for asthma.Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD011714. doi: 10.1002/14651858.CD011714.pub2. Cochrane Database Syst Rev. 2016. PMID: 27486836 Free PMC article.
-
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms: FUTURE, a superiority RCT and economic evaluation.Health Technol Assess. 2025 Jul;29(27):1-139. doi: 10.3310/UKYW4923. Health Technol Assess. 2025. PMID: 40620147 Free PMC article. Clinical Trial.
-
Urodynamics tests for the diagnosis and management of male bladder outlet obstruction: long-term follow-up of the UPSTREAM non-inferiority RCT.Health Technol Assess. 2025 Jul;29(26):1-57. doi: 10.3310/SLPT4675. Health Technol Assess. 2025. PMID: 40619891 Free PMC article. Clinical Trial.
-
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693988 Free PMC article.
References
-
- V. Phe, E. Chartier‐Kastler, and J. N. Panicker, “Management of Neurogenic Bladder in Patients With Multiple Sclerosis,” Nature Reviews Urology 13 (2016): 275–288.
-
- J. M. Gelfand, “Multiple Sclerosis: Diagnosis, Differential Diagnosis, and Clinical Presentation,” Handbook of Clinical Neurology 122 (2014): 269–290.
-
- J. H. Seth, A. Sahai, and J. N. Panicker, “Lower Urinary Tract Dysfunction in Multiple Sclerosis,” Current Bladder Dysfunction Reports 7 (2012): 97–104.
-
- A. Tubaro, F. Puccini, C. De Nunzio, et al., “The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review,” Current Urology Reports 13 (2012): 335–342.
-
- V. Phé, M. Pakzad, C. Curtis, et al., “Urinary Tract Infections in Multiple Sclerosis,” Multiple Sclerosis (Houndmills, Basingstoke, England) 22 (2016): 855–861.
Grants and funding
LinkOut - more resources
Full Text Sources